Key result
Rapamycin did not inhibit IGF-II-induced proliferation or differentiation of rat, mouse, or human skeletal muscle cells, indicating p70 S6 kinase is not required for this process.
p70 S6 kinase activation is not required for IGF-induced differentiation of skeletal muscle cells, whereas PI 3-kinase is essential.
Answers are grounded in this paper and cite their sources.
p70 S6 kinase is dispensable for IGF-II myogenesis; leaves open PI3K effector mechanisms in skeletal muscle differentiation.
Insulin-like growth factors (IGFs) are potent stimulators of muscle differentiation, and phosphatidylinositol 3-kinase (PI 3-kinase) is an essential second messenger in this process. Little is known about the downstream effectors of the IGF/PI 3-kinase myogenic cascade, and contradictory observations have been reported concerning the involvement of p70 S6 kinase. In an attempt to clarify the role of p70 S6 kinase in myogenesis, here we have studied the effect of rapamycin on rat, mouse, and human skeletal muscle cell differentiation. Both insulin and IGF-II activated p70 S6 kinase in rat L6E9 and mouse Sol8 myoblasts, which was markedly inhibited at 1 ng/ml rapamycin concentrations. Consistent with previous observations in a variety of cell lines, rapamycin exerted a potent inhibitory effect on L6E9 and Sol8 serum-induced myoblast proliferation. In contrast, even at high concentrations (20 ng/ml), rapamycin had no effect on IGF-II-induced proliferation or differentiation. Indeed, neither the morphological differentiation, as assessed by myotube formation, nor the expression of muscle-specific markers such as myogenin, myosin heavy chain, or GLUT4 (glucose transporter-4) glucose carriers was altered by rapamycin. Moreover, here we extended our studies on IGF-II-induced myogenesis to human myoblasts derived from skeletal muscle biopsies. We show that, as observed for rat and mouse muscle cells, human myoblasts can be induced to form multinucleated myotubes in the presence of exogenous IGF-II. Moreover, IGF-II-induced human myotube formation was totally blocked by LY294002, a specific PI 3-kinase inhibitor, but remained unaffected in the presence of rapamycin.
No takes yet. Share an insight, caveat, or question.
Canicio et al. (1998) studied Skeletal muscle cell differentiation. Rapamycin vs. LY294002 or no rapamycin was evaluated on IGF-II-induced myoblast proliferation and differentiation (myotube formation and muscle-specific marker expression). Rapamycin did not inhibit IGF-II-induced proliferation or differentiation of rat, mouse, or human skeletal muscle cells, indicating p70 S6 kinase is not required for this process.
Synapse has enriched 10 related papers. Consider them for comparative context: